Jennifer E. Sager
VIR Biotechnology (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Pharmaceutical studies and practices
Most-Cited Works
- → Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification(2015)497 cited
- → Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19(2022)289 cited
- → Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans(2008)134 cited
- → Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions(2013)109 cited
- → Fluoxetine- and Norfluoxetine-Mediated Complex Drug–Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4(2014)79 cited
- → Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab(2021)52 cited
- → Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro(2016)43 cited
- → In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation(2016)40 cited
- → Physiologically Based Pharmacokinetic Model of the CYP2D6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions(2017)33 cited
- → Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters(2017)31 cited